Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
Mary Mansfield(Trinity College Dublin), Thomas R. Rogers(Scripps Research Institute), Anne Marie McLaughlin(St. James's Hospital), Margaret Fitzgibbon(Trinity College Dublin), Emma Roycroft(Trinity College Dublin), Joseph Keane(Trinity College), Lorraine Montgomery(St. James's Hospital)
Cited by 15
Related Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
|New England Journal of Medicine|2001|3.7k
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426